<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30046204</PMID>        <DateRevised>            <Year>2018</Year>            <Month>07</Month>            <Day>29</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0253-0716</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>43</Volume>                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Jul</Month>                    </PubDate>                </JournalIssue>                <Title>Iranian journal of medical sciences</Title>                <ISOAbbreviation>Iran J Med Sci</ISOAbbreviation>            </Journal>            <ArticleTitle>Medullary Breast Carcinoma and Invasive Ductal Carcinoma: A Review Study.</ArticleTitle>            <Pagination>                <MedlinePgn>365-371</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Medullary breast carcinoma (MBC) is a unique histological subtype of breast cancer. The present study aimed to evaluate the classic and non-classic characteristics of MBC and its differences with IDC. The present review study incorporates 22 years of practical experience from a breast disease research center-based series of cases.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Retrospectively, the medical records of 3,246 patients were reviewed in the Breast Disease Research Center, Shiraz University of Medical Science (Shiraz, Iran), from December 1993 to December 2015. The tumor size, lymph node metastasis, pathologic stage, nuclear and histological grade, hormonal receptor status, recurrence, disease-free, and overall survival were reviewed. Differences between medullary breast carcinoma and invasive ductal carcinoma were analyzed statistically using the Chi-square, Fischer, independent-sample <i>t</i> test, and Kaplan-Meier analysis (SPSS version 19.0). P&lt;0.05 were considered statistically significant.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 179 patients were identified with MBC and 3,067 patients were identified with IDC. The MBC group had a significant association with a higher histological grade (P&lt;0.001) as well as negative estrogen receptor (P&lt;0.001), progesterone receptor (P&lt;0.001), and HER-2 (P=0.004) status. The MBC patients predominantly had triple-negative breast cancer (TNBC) according to the molecular subtype (P&lt;0.001). In local invasion, MBC was less invasive compared to IDC (P&lt;0.001). The disease-free survival (DFS) and overall survival (OS) differed significantly between the MBC and IDC groups (5-year DFS: 94.2% vs. 86.3%, P=0.008; 5-year OS: 98.1% vs. 92.8%, P=0.004).</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Despite the poor and aggressive pathological features of MBC, its clinical outcome is more favorable compared to IDC. Our findings can be useful in improvement of diagnosis and treatment of less known breast cancer subtypes, such as MBC.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Zangouri</LastName>                    <ForeName>Vahid</ForeName>                    <Initials>V</Initials>                    <Suffix> MD</Suffix>                    <AffiliationInfo>                        <Affiliation>Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Akrami</LastName>                    <ForeName>Majid</ForeName>                    <Initials>M</Initials>                    <Suffix> MD</Suffix>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Division of Surgical Oncology, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tahmasebi</LastName>                    <ForeName>Sedigheh</ForeName>                    <Initials>S</Initials>                    <Suffix> MD</Suffix>                    <AffiliationInfo>                        <Affiliation>Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Talei</LastName>                    <ForeName>Abdolrasoul</ForeName>                    <Initials>A</Initials>                    <Suffix> MD</Suffix>                    <AffiliationInfo>                        <Affiliation>Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ghaeini Hesarooeih</LastName>                    <ForeName>Ali</ForeName>                    <Initials>A</Initials>                    <Suffix> MD</Suffix>                    <AffiliationInfo>                        <Affiliation>Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Iran</Country>            <MedlineTA>Iran J Med Sci</MedlineTA>            <NlmUniqueID>8104374</NlmUniqueID>            <ISSNLinking>0253-0716</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2010 Jun;56(7):852-9</RefSource>                <PMID Version="1">20636789</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2010 Nov 11;363(20):1938-48</RefSource>                <PMID Version="1">21067385</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 1990 Oct;16(3):215-29</RefSource>                <PMID Version="1">2085673</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2014 Dec;14(6):390-5</RefSource>                <PMID Version="1">25034440</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2013 Feb;13(1):31-9</RefSource>                <PMID Version="1">23098574</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2005 Oct 31;93(9):1046-52</RefSource>                <PMID Version="1">16175185</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300</RefSource>                <PMID Version="1">20610543</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Opin Oncol. 2008 Nov;20(6):614-20</RefSource>                <PMID Version="1">18841042</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2010 Jul;17(7):1862-9</RefSource>                <PMID Version="1">20162457</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2014;15(19):8191-5</RefSource>                <PMID Version="1">25339004</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2004 Jan-Mar;5(1):24-7</RefSource>                <PMID Version="1">15075000</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathology. 2009 Jan;41(1):48-56</RefSource>                <PMID Version="1">19089740</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br Med Bull. 2012 Sep;103(1):129-45</RefSource>                <PMID Version="1">22864058</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomed Imaging Interv J. 2009 Oct;5(4):e27</RefSource>                <PMID Version="1">21610994</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2008 Dec;8 Suppl 4:S171-8</RefSource>                <PMID Version="1">19158038</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Surg. 2007 Oct;194(4):527-31</RefSource>                <PMID Version="1">17826073</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2012 Nov;23(11):2843-51</RefSource>                <PMID Version="1">22707751</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Apr 19;7(16):22665-73</RefSource>                <PMID Version="1">27009810</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 1992 Jun;20(6):479-89</RefSource>                <PMID Version="1">1607149</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1040-7</RefSource>                <PMID Version="1">15990007</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Oncol. 2008 Jun;30(2):96-101</RefSource>                <PMID Version="1">18566570</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):152-9</RefSource>                <PMID Version="1">15093911</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>NMR Biomed. 2010 Jul;23(6):619-23</RefSource>                <PMID Version="1">20232453</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Biochem Biophys. 2015 Jun;72(2):333-8</RefSource>                <PMID Version="1">25543329</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1977 Oct;40(4):1365-85</RefSource>                <PMID Version="1">907958</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2006 Feb 15;98(4):262-72</RefSource>                <PMID Version="1">16478745</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2014;15(19):8499-502</RefSource>                <PMID Version="1">25339054</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Surg Oncol. 2013 Apr 22;11:91</RefSource>                <PMID Version="1">23607710</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Oncol. 2011 Sep;28(3):738-44</RefSource>                <PMID Version="1">20390465</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Breast Cancer. 2013 Dec;16(4):417-25</RefSource>                <PMID Version="1">24454464</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N"> Breast </Keyword>            <Keyword MajorTopicYN="N"> Carcinoma </Keyword>            <Keyword MajorTopicYN="N"> Ductal </Keyword>            <Keyword MajorTopicYN="N"> Medullary </Keyword>            <Keyword MajorTopicYN="N"> Prognosis </Keyword>            <Keyword MajorTopicYN="N"> Survival</Keyword>            <Keyword MajorTopicYN="N">Carcinoma </Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>7</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30046204</ArticleId>            <ArticleId IdType="pmc">PMC6055214</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>